The company's new Sugar Land, TX distribution facility is the second for Quva, as it expands its 503B forward distribution capabilities and adds another 20,000 sq. ft. of distribution capacity. The ...

SUGAR LAND, Texas, Nov. 11, 2019 /PRNewswire/ -- QuVa Pharma, Inc. announced today that is has launched a new flag label design for its syringe product portfolio of compounded sterile products (CSPs) ...

August 24, 2015 – QuVa Pharma, Inc., a newly formed national platform for sterile compounding pharmacy services led by two experienced industry executives, announces it has completed the acquisition ...

SUGAR LAND, Texas, Jan. 6, 2026 /PRNewswire/ -- QuVa Pharma, Inc (Quva), a national, industry-leading provider of outsourced sterile injectable compounding services and health-system pharmacy data and ...

QuVa Pharma, a provider of essential medications in ready-to-administer injectable formats to hospitals, has secured a $275 million senior debt facility. Goldman Sachs was the lead backer with ...

QuVa Pharma, Inc. has announced it has signed an agreement to acquire an FDA approved biotech pharmaceutical facility in New Jersey. QuVa Pharma currently operates two Texas-based 503B registered ...

In its next step in the march to becoming a national powerhouse, Sugar Land's QuVa Pharma announced Tuesday it had acquired a second pharmaceutical manufacturing company in less than three months.

Sugar Land, TX– November 2, 2015 – QuVa Pharma, Inc., a newly formed national platform for sterile compounding pharmacy services, has acquired the assets of Unique Pharmaceuticals, Ltd., including its ...

— Establishment Inspection Report is one of the first issued to a registered 503B sterile outsourcing compounder by the FDA — Sugar Land, TX – December 21, 2015 – QuVa Pharma, Inc., a newly formed ...